Clinical trial
Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman…
NCT00092222 · National Cancer Institute (NCI), NIH · Active, not recruiting
Key facts
| NCT number | NCT00092222 |
|---|---|
| Title | Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity |
| Official title | Targeted Oncolytic Virotherapy and Natural History Study of KSHV-Associated Multicentric Castleman's Disease With Laboratory and Clinical Correlates of Disease Activity |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Active, not recruiting |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoproliferative Disorder, HHV-8, Malignancy, HIV |
| Intervention type | Drug, Other |
| Interventions | Etoposide, Interferon-alpha, Rituximab, Zidovudine, Liposomal Doxorubicin, Bortezomib, Valganciclovir, Doxorubicin, Vincristine, Cyclophosphamide and 4 more |
| Enrollment | 75 |
| Start date | Oct 28, 2004 |
| Primary completion | Oct 1, 2026 |
| Completion | Oct 1, 2026 |
| First posted | Sep 22, 2004 |
| Last update posted | Feb 5, 2026 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: